Hilleman licenses oral cholera vaccine Hillchol to Bharat Biotech
Collaboration seeks to accelerate the development, licensure, manufacture and supply of an affordable, next-generation cholera…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Hilleman Laboratories
Browsing Tag
Hilleman Laboratories
With our heat-stable rotavirus vaccine, we aim to support the govt’s efforts to reduce child…
Hilleman Laboratories has recently initiated phase I/ II clinical trials for both rotavirus and cholera vaccines in Bangladesh. Dr…
The importance of skill from research to delivery of vaccines
Dr Davinder Gill, CEO, Hilleman Laboratories, roots for an educational programme for vaccinators to hone their skills and make…
Hilleman Lab to invest Rs 300 crore to develop low-cost vaccines
The company is developing a synthetic vaccine to fight meningitis in Asian, African and Latin American countries
Hilleman…
Naveen Amar of Hilleman Laboratories bags awards
Receives the ‘100 most influential CFO’s of India’ and Best CFO of the year -Pharmaceutical and Biotech award
Naveen Amar,…
Hilleman Laboratories’ preclinical trial report on Hib vaccine offers hope to millions of children
The unique formulation will not only be cost effective but also scalable for commercial manufacturing
Global vaccine research and…
Hilleman Laboratories to extend its thermostable formulations to other vaccines
The company plans to support India’s aim of achieving 90 per cent coverage through its expanded programme by 2020
Hilleman Laboratories’ Thermostable technology extends its support towards other vaccines
The company plans to support India’s aim of achieving 90 per cent coverage through its expanded programme by 2020
Hilleman Laboratories signs MoU with icddr,b
Hilleman will provide its expertise in the further development and icddr,b will provide expertise with respect to clinical…